U.S. employers grappling with mounting expenses linked to covering obesity drugs like Novo Nordisk A/S's (NYSE: NVO) Wegovy and Eli Lilly And Co's (NYSE: LLY) Zepbound are increasingly turning to virtual healthcare providers such as Teladoc Health Inc (NYSE: TDOC) to administer weight-loss management initiatives.
Citing a benefits consultant, Reuters noted that employers aiming to curtail expenses might confine employees to smaller networks of more cost-effective providers or institute lifestyle changes as a prescription prerequisite.
Others emphasized the potential for long-term health improvements via diet and exercise regimens.
Teladoc's Ananth Balasubramanian noted the shifting perspective ...